Apotheek Spaanse Kroon SA
Apotheek Spaanse Kroon reported total assets of 110,316 € at the end of the 2025 financial year (annual accounts filed with the NBB on 31 Aug 2026).
The score of Apotheek Spaanse Kroon shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +34 % Total assets -10 %
Accounts of the company itself (not consolidated).
The full file covers 13 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Apotheek Spaanse Kroon's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 31 Aug 2026
- Year ended 31 Dec 2024filed on 29 Aug 2025
- Year ended 31 Dec 2023filed on 27 Aug 2024
- Year ended 31 Dec 2022filed on 31 Jul 2023
- Year ended 31 Dec 2021filed on 29 Jul 2022
Apotheek Spaanse Kroon's financial analysis
- Solvency33.2%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Apotheek Spaanse Kroon
Apotheek Spaanse Kroon's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0462.374.749
- VAT number
- BE0462374749
- Peppol
- Registered · 0208:0462374749 · as of 10 Nov 2026
- Legal form
- SA
- Incorporated
- 23 Jan 1998
- Registered office
- 3000 Leuven
- Latest accounts
- 2025 · filed on 31 Aug 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Apotheek Spaanse Kroon (SA) has been based in Leuven since 1998, active in: retail sale of pharmaceutical products. For 2025, it reports a net loss of 866 € and equity of 36,631 €; its revenue is not published.
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Apotheek Spaanse Kroon
Companies in the same business, of comparable size and area, outside its group.
- Pharmacie VERHEYDEN Retail sale of pharmaceutical products Brussels · balance sheet 135,673 €
- Grodt Retail sale of pharmaceutical products Uccle · balance sheet 109,794 €
- Selvipharma Retail sale of pharmaceutical products Brussels · balance sheet 109,734 €
- Pharmanou Retail sale of pharmaceutical products Sprimont · balance sheet 112,116 €
- Parapharmacie Discount Braine l'Alleud Retail sale of pharmaceutical products Braine-l'Alleud · balance sheet 113,264 €
- PPPharmacy Retail sale of pharmaceutical products Ghent · balance sheet 106,768 €
- Merckx Retail sale of pharmaceutical products Wichelen · balance sheet 106,701 €
- Make A Better Move Retail sale of pharmaceutical products Genappe · balance sheet 114,527 €
Frequently asked questions about Apotheek Spaanse Kroon
What is the revenue of Apotheek Spaanse Kroon?
Apotheek Spaanse Kroon files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Apotheek Spaanse Kroon?
In Belgium, the VAT number is the company number prefixed with BE: BE0462374749 for Apotheek Spaanse Kroon, if the company is VAT-registered. Its company number (CBE) is 0462.374.749.
Where is the registered office of Apotheek Spaanse Kroon?
According to the CBE register, the registered office of Apotheek Spaanse Kroon is in 3000 Leuven.
What is the equity of Apotheek Spaanse Kroon?
At the close of the 2025 financial year, the equity of Apotheek Spaanse Kroon amounts to 36,631 €, a solvency of 33.2% of total assets.
Who manages Apotheek Spaanse Kroon?
The register lists 2 active mandates at Apotheek Spaanse Kroon. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Apotheek Spaanse Kroon
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →